With the advent of AI, the world is rapidly changing. Are you interested in learning about the latest trends across various industries? Today, we utilize FactSet transcript data and apply an LLM model to summarize and analyze what executives and CEOs are discussing regarding their understanding and insights on current trends within their respective domains.

First, access to transcript data, which FactSet collects, organizes, and makes available to its clients. This data aids investors, analysts, and other stakeholders in making informed decisions based on the company’s communicated information. The transcript data provides detailed information on corporate events, with hourly updates and weekly full refreshes. These transcripts cover events for over 49,000 companies (about 39,000 active companies). We utilize Elasticsearch technology to quickly examine data from February 24, 2023, to August 23, 2024, at three-month intervals for companies focused on RBICS Healthcare sector and are listed in developed countries: Japan, Taiwan, the United Kingdom, Germany, South Korea, the United States, France, Italy, Finland, Israel, and Canada. We also filter companies to have its total market capitalization equal or greater than $5 billion and an average daily trading volume equal or greater than $20 million.

Then leverage OpenAI’s LLM model, GPT-4-0513 via API to analyze and summarize all these transcripts, resulting in the following analysis:

• February 24, 2023: There is a focus on health empowerment and data utilization, with consumers seeking health information to modify behaviors. International market growth is noted outside the United States, particularly in the JAPAC region. There’s a significant shift towards at-home healthcare solutions and healthcare digitization. Macro pressures are observed with expectations of a downward trend in inflationary pressures on raw materials in the latter half of the year.
• May 26, 2023: Strong international market growth in China, Japan, and Europe. A rising preference for biologics and vaccines, and an increasing need for pharmacy automation due to labor shortages. There’s improved retention and work-life balance among licensed healthcare workers, boosting staffing levels. The demand for vision correction is rising, driven by increased screen time and myopia rates. There’s a significant shift towards ambulatory sites of care and a trend towards sustainable materials.
• August 25, 2023: Increased automation in the healthcare sector, particularly in nursing and staff management, with care shifting to the home. Rising prevalence of myopia due to digital screen use, leading to higher demand for vision correction products. Higher utilization trends in Medicare Advantage with increased outpatient services. Growing pet ownership among Gen Z and Millennials, leading to higher spending on veterinary care.
• November 24, 2023: Improvement in the global supply chain environment and business, despite some mix differences and increased investments. Increased use of GLP-1s, long-term wearable injectors, and a rise in value-based procurement tenders post-COVID. Normalization in pharma demand and spending with a strong pipeline in clinical trials. A trend towards earlier stage cancer treatments and specific vaccines as global economies recover from the pandemic.
• February 23, 2024: An aging population is increasingly prioritizing healthcare and nutrition, with expanded reimbursement coverage for diabetes treatments. Steady upward trend in capital investment and business momentum. Growing trend towards mail order pharmacies and bio-resorbable materials in medical products. Continued growth in at-home healthcare solutions and a sustained market for PPE. Increasing demand for vision correction, particularly among children, and a shift towards higher-value products.
• May 24, 2024: Increasing demand for healthcare services driven by demographics, particularly the aging population. Strong growth in diagnostics and infusion pump businesses, particularly in the US market. Rising trend in the adoption of continuous glucose monitoring systems for diabetes management. Increasing utilization of advanced heart valve replacement technologies and combination therapies in oncology. Significant trend towards subcutaneous therapies and global demand for immunoglobulin products.
• August 23, 2024: Notable rise in mergers and acquisitions within the sector, with transaction multiples trending lower. Significant growth in biologics and wearable injectors. Migration towards more Ambulatory Surgery Centers and healthcare moving into the home. Increased demand for vision correction products globally. A 78% year-over-year rise in biopharma funding and a trend in China towards healthcare independence.